Aurobindo Pharma
Pattern Identification: Support and Resistance
Time Frame: Daily Chart
Key Observations:
Support and Resistance Zones:
Upper Resistance Zone (Rs. 1550 to Rs. 1600):
The top blue-shaded area represents a significant resistance zone where the price was previously rejected. This range has acted as a ceiling for the stock, with multiple instances of price rejection, indicating strong selling pressure around these levels. Any attempt to move beyond Rs. 1550-1600 has seen sellers take control, pushing the price down. This level remains a critical barrier to upward movement.
Support Levels:
Current Support Zone (Rs. 1350 to Rs. 1380):
The stock is currently near the support zone between Rs. 1350 and Rs. 1380, highlighted by the middle blue shaded area. This range has previously acted as a base where buyers stepped in to prevent further declines, turning it into a demand zone.
If this zone holds, it may provide a platform for a potential reversal or consolidation. The price is close to this support, and its behavior here will be crucial in determining if a bounce is likely.
Lower Support Zone (Rs. 1150 to Rs. 1200):
The lowest blue-shaded area, between Rs. 1150 and Rs. 1200, indicates another significant support zone. This area has been tested, providing a foundation for the stock to rebound upward. Should the price break below the current support (Rs. 1350–1380), this lower zone could be the next major support. If the stock declines to this level, it could attract buyers again, as observed historically.
Current Scenario:
Price Action:
Aurobindo Pharma is trading at Rs. 1407.20, which shows a slight upward movement within the day.
The stock has been experiencing a downward correction after failing to break through the Rs. 1550 to Rs. 1600 resistance zone. This correction has brought the price down towards the Rs. 1350 to Rs. 1380 support zone.
The current price action around this support level will be critical in determining if the stock can reverse from here or if a further decline is likely.
Market sentiment and momentum:
Bearish Bias in the Short Term: The stock has been forming lower highs since reaching its recent peak near the resistance zone, indicating bearish sentiment. The price’s approach to the Rs. 1350–1380 support zone suggests that buyers may soon test their ability to counteract this downtrend.
Cautiously Bearish: The overall sentiment appears cautiously bearish due to the recent price rejection at the Rs. 1550-1600 level, followed by a downward trend. However, a strong defense of the Rs. 1350-1380 support zone could shift sentiment to a more neutral or bullish stance if buyers step in with significant volume.
Volume Analysis: Volume activity near this support zone will be essential for confirming any potential reversal. A bounce from Rs. 1350–1380 with increased buying volume would suggest renewed interest among buyers, whereas a breakdown below Rs. 1350 with high selling volume could confirm further downside.
Possible Scenarios:
Bullish Scenario:
Bounce from Rs. 1350-Rs. 1380 Support Zone:
Suppose the stock maintains its position above the Rs. 1350-Rs. 1380 support zone, it could signal a bullish reversal. Traders may look for bullish candlestick patterns (e.g., hammer, bullish engulfing, or morning star) around this support level, which would confirm buying interest.
Upside Targets:
In a bullish scenario, the first target would be around Rs. 1450, a minor resistance level, followed by a potential move toward the key resistance zone at Rs. 1550 to Rs. 1600. A breakout above Rs. 1600 would signal a substantial bullish reversal, with the possibility of further upside towards Rs. 1650 or higher in the coming weeks.
Volume Confirmation:
Higher buying volume around the Rs. 1350–1380 level would add confidence to the bullish case. Without volume support, any bounce could be limited. Traders should watch for an increase in volume to confirm the strength of any upward move.
Bearish Scenario:
Breakdown Below Rs. 1350:
If the stock fails to hold the Rs. 1350 to Rs. 1380 support zone, it could lead to a breakdown, pushing the price towards the next significant support zone between Rs. 1150 and Rs. 1200. Such a breakdown would likely indicate continued bearish sentiment, potentially triggering a sharper decline.
Target for Decline:
In the bearish case, the immediate target would be around Rs. 1150 to Rs. 1200, which previously acted as a strong support zone. A breakdown below Rs. 1150 would signal a more prolonged bearish phase, possibly opening up further downside toward Rs. 1100 or even lower.
Bearish Continuation Patterns:
Traders should monitor for bearish candlestick patterns (such as a bearish engulfing or three black crows) if the price approaches the Rs. 1350 level. Additionally, patterns like a descending triangle or a bear flag around this area would confirm bearish momentum if they form. High volume during a breakdown below Rs. 1350 would validate a continuation of the downtrend.
Conclusion:
Bullish Case: If the stock can sustain above the Rs. 1350 to Rs. 1380 support zone with strong buying volume, it could stage a rebound toward Rs. 1450, with further potential toward the Rs. 1550 to Rs. 1600 resistance zone. A breakout above Rs. 1600 would confirm a bullish shift, with an upward target around Rs. 1650 or higher.
Bearish Case: A break below Rs. 1350 would indicate a bearish continuation, with the next downside target at Rs. 1150 to Rs. 1200. Failure to hold this level would suggest additional downside risks, potentially bringing the stock below Rs. 1100.
Aurobindo Pharma is currently at a crucial support level. The next few days’ price action, especially around Rs. 1350–1380, will be pivotal in defining its trend. Watch for volume and candlestick patterns for confirmation of either a bounce or breakdown.
Disclaimer:
The information provided in this article is for educational and informational purposes only and should not be considered financial advice. Investment in the stock market involves risk, and you should research or consult a licensed financial advisor before making any investment decisions.
News of the day:
Indian stock markets plummeted on Monday, with the Sensex dropping 942 points to close at 78,782.24 and the Nifty falling 309 points to settle at 23,995.35. Among the top losers were Hero MotoCorp, Grasim Industries, Bajaj Auto, Adani Ports, Reliance Industries, and Sun Pharma. Despite the downturn, some stocks managed gains, including Mahindra & Mahindra, Tech Mahindra, Cipla, SBI, HCL Tech, and Infosys.
The Sensex plunged 942 points, closing at 78,782, while the Nifty dropped 309 points to end at 23,995, as investor caution heightened ahead of the upcoming US election and the Federal Reserve meeting. Analysts noted that lackluster Q2 earnings are impacting market sentiment. “Investors are adopting a sell-on-any-rise approach,” commented Palka Arora Chopra of Master Capital Services.
CarDekho is reportedly planning to raise between ₹3,000 crore and ₹4,000 crore through an initial public offering (IPO) next year and is currently in discussions with investment banks, as per Moneycontrol. The IPO is expected to include both a fresh issuance of shares and an offer for sale. CarDekho was co-founded by Amit Jain and Anurag Jain in 2008.
Mukesh Ambani is aiming for a 2025 IPO for Jio, which analysts estimate could be valued at over $100 billion, Reuters reported. If successful, this IPO could surpass Hyundai India’s as the largest in India’s history. Meanwhile, the IPO for Reliance Retail is expected to follow later due to ongoing internal business and operational adjustments. In 2019, Ambani announced plans to position Jio and Reliance Retail for a public listing within five years.
SEBI has advised investors against using apps and platforms that provide virtual trading, paper trading, or fantasy games based on the stock prices of listed companies. The regulator warned, “Participation in unauthorized schemes… is at investors’ own risk, cost, and consequences, as such schemes/platforms aren’t registered with SEBI.” SEBI also noted that these platforms lack investor protection safeguards.
